Neelima Vidula

14PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 24, 2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

|Jan 27, 2025
Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer.

Rupali Sood, Andrzej Niemierko, Lianne Ryan

|Jan 02, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

Rachel O Abelman, Bogang Wu, Haley Barnes

|Apr 11, 2024
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer.

Yael Bar, Jennifer C Keenan, Andrzej Niemierko

|Jan 19, 2024
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer.

Kelly E McCann, Shari B Goldfarb, Tiffany A Traina

|Sep 07, 2023
Glutaminase (GLS1) gene expression in primary breast cancer.

Neelima Vidula, Christina Yau, Hope S Rugo

Pageof 3

Frequent Collaborators

3 joint publications

Dejan Juric

3 joint publications

Leif W Ellisen

3 joint publications

Steven J Isakoff

3 joint publications

Beverly Moy